Texas Equine Veterinary Association

The Remuda | Fall 2023 Edition 24 ArthramidVet is manufactured by Contura International, in its FDA regulated, GMP (Good Manufacturing Practice) manufacturing facility located outside of Copenhagen, Denmark. Visit www.contura. com to watch a video tour of our manufacturing facility. Contura has been developing and manufacturing 2.5 iPAAG for over 23 years. The 2.5 iPAAG made by Contura is not only licensed for use in horses in over 40 jurisdictions around the globe, the formula is also approved for several label indications for human use as well. In fact, Contura International is the only company with an FDA approved polyacrylamide for human use in the United States. You will be hard pressed to find another company that has more published research on a product than Contura's 2.5 iPAAG. You can read the newest three-year data on Arthrosamid—Contura's 2.5 iPAAG for knee osteoarthritis in humans—on Contura's website. You will also find plentiful published articles and papers on ArthramidVet in horses, humans, dogs, rabbits, and goats. In addition, Contura continues investing in new research in horses, humans, and dogs with new studies currently underway. Megan Green, DVM Technical Services Veterinarian, ConturaVet USA Megan.Green@conturavet. com Michaela Arcaro Director of Operations ConturaVet USA Michaela.Arcaro@conturavet. com [1] Tnibar, A., Persson, A., Jensen, H.E., Svalastoga, E., Westrup, U., McEvoy, F., Evaluation of a polyacrylamide hydrogel in the treatment of induced osteoarthritis in a goat model: A pilot randomized controlled Study [abstract]. Osteoarthritis Cartilage. 2014; 22: 477. ConturaVet is a Platinum Sponsor of TEVA and publishing this article in The Remuda is a part of their sponsorship package. If you would like more information on becoming a TEVA Sponsor please visit our website at www.texasequineva.com. "At Contura, everything we do is rooted in innovation and advancing medicine for patients. Arthramid helps veterinarians treat and manage lameness caused by synovitis and osteoarthritis. Based on a 2.5% cross-linked injectable polyacrylamide hydrogel (iPAAG), Arthramid is a visco-elastic bio- scaffold that works by integrating into the synovium allowing new synovial tissue to grow, resulting in long lasting improvement in joint function and resolution of lameness," —Michaela Arcaro, Director of Operations ConturaVet USA

• Cover